The Complete Tirzepatide Injections Guide: Uses, Dosing, Safety

By the ShopMedRx team. This article is general education for adults 18 and older. It is not medical advice.

Tirzepatide is a once-weekly injection that acts on two gut-hormone pathways, called GIP and GLP-1, and it is prescribed to support weight management in some adults. It is a prescription-only medicine, so a licensed clinician has to decide whether it is appropriate for you. This tirzepatide injections guide walks through what it is, how it works, who it may suit, how treatment starts, how dosing is labeled, the main risks, and what to ask before you begin.^[1][7]

Your tirzepatide injections guide: the short version

If you only have a minute, here is the plain-language summary. Each section below gives a short overview and, where we have a deeper article, a link to it.

• What it is: an injectable medicine taken under the skin once a week.
• What it does: it works on GIP and GLP-1 receptors, which are involved in appetite and blood sugar.
• Who it may suit: some adults with obesity, or with overweight plus a weight-related health condition, after a clinician reviews their history.
• How it starts: an online health assessment, a licensed clinician's review, and a prescription only if it is appropriate.
• Main risks: stomach side effects are common, and there is a boxed warning about thyroid C-cell tumors seen in rats.
• Not a stand-alone fix: it is meant to be used alongside a reduced-calorie diet and more physical activity.

What tirzepatide injections are

Tirzepatide is a medicine given by subcutaneous injection, which means a small injection into the fat layer under the skin. It is taken once a week. In the United States, an FDA-approved tirzepatide product is approved for adults for type 2 diabetes, for chronic weight management in adults with obesity, and for moderate to severe obstructive sleep apnea in adults with obesity.^[7]

Weight-management use is meant to be paired with lifestyle changes. The labeled approach is a reduced-calorie diet and increased physical activity, with the medicine added on top, not used instead of them.^[1]

Why "compounded" matters

Most ShopMedRx products, including our Tirzepatide Injections, are compounded. A compounded medicine is prepared by a licensed pharmacy for an individual patient after a prescriber orders it. Compounded medications are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality.^[5]

That is an important fact to understand before you decide anything. It is also why the safety information in this guide comes from the FDA label and published trials of FDA-approved tirzepatide: those are the best public sources about how the medicine behaves, even though they describe a different product than a compounded prescription. Your clinician can explain what that means for you.

How tirzepatide works

Tirzepatide is a dual agonist, which means it activates two hormone receptors: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1).^[7] These hormones are released from the gut after you eat. They help signal fullness and help the body manage blood sugar.

According to the FDA label, tirzepatide lowers fasting and after-meal blood sugar, decreases food intake, and reduces body weight.^[6] In everyday terms, many people notice that they feel full sooner and think about food less. That change in appetite is what can make it easier to eat fewer calories, which is the main way weight change happens.

Because tirzepatide acts on GLP-1 receptors, the label says it should not be used together with other tirzepatide-containing products or with any other GLP-1 receptor agonist.^[1] Tell your clinician about every medicine and supplement you take.

What the clinical trials found

The large trials of FDA-approved tirzepatide are the main evidence people point to. Here is what three of them reported. These are averages from study groups, and individual results vary.

Trial	Who took part	What the study reported at 72 weeks
SURMOUNT-1	Adults with obesity, or overweight plus a related condition, without diabetes	Average weight change of -15.0% (5 mg), -19.5% (10 mg) and -20.9% (15 mg), versus -3.1% with placebo[2]
SURMOUNT-2	Adults with obesity or overweight and type 2 diabetes	Average change of -12.8% (10 mg) and -14.7% (15 mg), versus -3.2% with placebo[3]
SURMOUNT-3	Adults who first completed a 12-week intensive lifestyle program	Additional average change of -18.4% with tirzepatide, versus a 2.5% change with placebo[4]

A few things help put these numbers in context. The trials lasted 72 weeks, which is well over a year, and the dose was raised slowly. In SURMOUNT-1, people also received monthly brief lifestyle counseling.^[4] People with type 2 diabetes lost less on average than people without it in these studies.^[3]

Averages hide a wide range. Some participants lost more than the average, and some lost less. Results with a compounded prescription may also differ from trial results, so treat the table as background, not a prediction for yourself.

Who tirzepatide may be suitable for

Tirzepatide is for adults. In the SURMOUNT-1 trial, people were included if they had a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher plus at least one weight-related health problem, and people with diabetes were excluded from that trial.^[2][11] A licensed clinician looks at your BMI, health history, other conditions and current medicines before deciding.

Who should not use it

The FDA label lists a personal or family history of medullary thyroid carcinoma (MTC), or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), as a reason not to use tirzepatide.^[1] It is also not for anyone with a known serious allergy to tirzepatide.

Other situations call for extra care and a direct conversation with a clinician. Examples include a history of pancreatitis, gallbladder disease, kidney problems, serious stomach or digestion problems, diabetic eye disease, pregnancy or plans to become pregnant, and breastfeeding.^[10] If you use insulin or a sulfonylurea for diabetes, the risk of low blood sugar can be higher, and your clinician may need to change those doses.

Being eligible for a first look is not the same as being approved. Some people will be told tirzepatide is not right for them, and that is a normal and safe result of a clinician's review.

For a deeper walk-through of uses, safety and the access process, see our article Tirzepatide Explained: Uses, Safety and How to Get It.

How treatment starts with a tirzepatide prescription online

When you ask about a tirzepatide prescription online, it helps to know the steps. At ShopMedRx, the process looks like this:

1. Online health assessment. You answer questions about your health history, medicines and goals. Only share what the assessment asks for, and use the secure form, not email or comments.
2. Independent clinician review. A licensed clinician through OpenLoop Health reviews your answers. They may ask follow-up questions, and they decide whether a prescription is appropriate. Approval is never guaranteed.
3. Pharmacy fulfillment. If a prescription is written, a licensed U.S. partner pharmacy prepares and ships it, with the instructions your clinician specified.
4. Follow-up. Treatment is adjusted over time based on how you tolerate it, so staying in touch with the care team matters.

The clinician may recommend a different approach or no medicine at all. That is part of why this review exists.

Tirzepatide dosage in general terms

Tirzepatide dosage is not one-size-fits-all, and your clinician sets your plan. To give you a general picture, here is how the FDA label for tirzepatide injection for weight management describes dosing. It is a reference for how the approved product is labeled, not a schedule for your own prescription.

Step	What the label describes
Starting dose	2.5 mg injected under the skin once weekly for 4 weeks[1]
Increases	Raised in 2.5 mg steps, after at least 4 weeks on the current dose, until a maintenance dose is reached[1]
Maintenance doses	5 mg, 10 mg or 15 mg once weekly for weight reduction; 10 mg or 15 mg for obstructive sleep apnea[8]
Maximum	15 mg once weekly[1]
Role of 2.5 mg	For starting treatment only, not a maintenance dose[8]

The label also says to consider response and tolerability when choosing a maintenance dose.^[1] In other words, the plan is meant to be adjusted for the person, and a lower maintenance dose can be a reasonable choice if a higher one causes problems.^[8]

Why units and milligrams can be confusing

Compounded injections are often supplied in vials, and the concentration can differ from one prescription to another. That means the number of "units" you draw up depends on your specific prescription. Always follow the written directions from your clinician and pharmacy, and ask them to show you if anything is unclear. Never guess or convert doses yourself. Our tirzepatide dosage chart explains steps and units in more detail.

How to inject tirzepatide: sites, rotation and storage

Tirzepatide is injected under the skin, and the usual areas are the abdomen, thigh or upper arm. It is common to rotate sites from one dose to the next.^[9] Rotating helps avoid irritation in one spot.

Your clinician or pharmacy will give storage and handling instructions for your exact prescription, including whether it needs refrigeration and how long it can be kept once started. Follow those instructions over any general advice online. For a practical walk-through of the thigh as an injection site, how to rotate, and storage basics, read Where to Inject Tirzepatide in Thigh: Spot, Rotation, Storage.

Tirzepatide side effects and safety

Every medicine has risks. Here is a plain summary of the main ones.

The boxed warning

Tirzepatide carries a boxed warning, which is the FDA's most serious type. In rats, tirzepatide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid carcinoma, in humans.^[1] Because of this, it should not be used by anyone with a personal or family history of MTC or MEN 2.^[1] Tell a clinician right away if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.

Common side effects

The most common side effects, reported in at least 5% of people, include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection-site reactions, fatigue, hypersensitivity reactions and burping.^[9] These are most often stomach-related. The slow dose increases described above are meant to help the body adjust.

Other serious risks to know about

Beyond the boxed warning, labels and clinical references describe several other concerns. They include acute pancreatitis, gallbladder problems, kidney problems, severe stomach issues, serious allergic reactions, low blood sugar, and changes to diabetic eye disease.^[10] Dehydration from vomiting or diarrhea can also strain the kidneys, so drinking enough fluid matters.

Contact a clinician promptly if you have severe, ongoing stomach pain (with or without vomiting), signs of dehydration, yellowing of the skin or eyes, vision changes, or swelling of the face or throat. Call 911 or go to an emergency room for symptoms of a severe allergic reaction.

Safety checklist

• Share your full medical and family history, especially thyroid cancer, MEN 2, pancreatitis and gallbladder disease.
• List all medicines, especially insulin or sulfonylureas.
• Do not combine tirzepatide with any other GLP-1 medicine.^[1]
• Tell your clinician if you are pregnant, planning pregnancy or breastfeeding.
• Report any new or worsening symptoms instead of waiting for them to pass.
• Do not stop, restart or change your dose on your own.

Diet, activity and lifestyle on tirzepatide

Medicine is only one part of weight management. The FDA label frames tirzepatide as an add-on to a reduced-calorie diet and more physical activity.^[1] In the SURMOUNT-3 trial, participants completed a 12-week intensive lifestyle program before starting tirzepatide or placebo, which shows how closely the two are linked in research.^[4]

Practical habits that clinicians often talk about include:

• Smaller, more frequent meals if large meals cause nausea or fullness.
• Enough protein at each meal, which may help you feel satisfied. Your clinician or a registered dietitian can suggest an amount that fits you.
• Plenty of fluids, especially if you have vomiting or diarrhea.
• Limiting greasy, very sugary or heavily fried foods if they upset your stomach.
• Regular movement and strength work that you enjoy and can keep up. Check with a clinician first if you have a medical condition.

For food ideas and a sample approach, see The GLP-1 diet: what to eat on semaglutide or tirzepatide.

Compounded tirzepatide and unapproved products: how to stay safe

The FDA has raised concerns about unapproved GLP-1 drugs sold for weight loss, including products sold online without proper oversight.^[5] Here are some safeguards worth using no matter where you get care:

• A prescription should come only after a licensed clinician reviews your health information.
• It should be filled by a licensed U.S. pharmacy.
• Be wary of any product labeled "not for human consumption." Those are not medicines you should inject.
• Be wary of anyone promising specific outcomes, no health review, or instant access.
• Remember that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality.^[5]

Questions to ask a clinician before you start

Appointments go faster when you arrive with questions. Consider asking:

• Is tirzepatide appropriate given my health history and my current medicines?
• What dose will I start on, how will it change, and who do I contact if I feel unwell?
• How should I handle nausea, constipation or other side effects?
• What are the signs that I should stop and call right away?
• How will we decide if the treatment is working, and for how long should I plan to take it?
• What should I do if I miss a dose?
• What happens to my plan if I want to stop or I become pregnant?
• Are there other options we should talk about, such as semaglutide injections or a lifestyle-only plan?

Frequently asked questions

Do I need a prescription for tirzepatide injections?

Yes. Tirzepatide is prescription-only. A licensed clinician reviews your health information and decides whether a prescription is appropriate, and approval is not guaranteed.

How often are tirzepatide injections taken?

The FDA label for tirzepatide injection for weight management describes one injection under the skin once a week. Treatment starts at a low dose and is raised in steps after at least 4 weeks.^[1] Your clinician sets the plan for your prescription.

What are the most common tirzepatide side effects?

Stomach-related effects such as nausea, diarrhea, vomiting, constipation and abdominal pain are the most common, along with injection-site reactions and fatigue.^[9] Serious risks include pancreatitis, gallbladder problems and kidney problems.^[10] Talk to a clinician about any symptom that worries you.

Who should not take tirzepatide?

People with a personal or family history of medullary thyroid carcinoma, or with MEN 2, should not use it.^[1] People with a serious allergy to tirzepatide should also avoid it. Your clinician will check other conditions and medicines too.

Is compounded tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality.^[5] They are made by licensed pharmacies for individual patients after a prescriber orders them.

Can I take tirzepatide with another GLP-1 medicine?

The label says using tirzepatide with other tirzepatide-containing products or any GLP-1 receptor agonist is not recommended.^[1] Always tell your clinician about every medicine you take.

Talk to a licensed clinician

Tirzepatide is not right for everyone, and only a licensed clinician can decide whether it is appropriate for you. If you would like a clinician to review your health information, you can start with a short online assessment. A prescription is only written if it is appropriate, and a clinician may recommend a different plan.

Check if you qualify

You can also read about our Tirzepatide Injections program. This article is for education only and does not replace advice from your own healthcare professional. Talk to a clinician before starting, stopping or changing any treatment.

Important information

• This article is for general education and is not medical advice. Talk to a licensed clinician before starting, stopping or changing any treatment.
• All medications available through ShopMedRx are prescription only and are prescribed only if appropriate after a licensed clinician's review.
• Some medications we offer are compounded. Compounded medications are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed. They are not the same as, or generic versions of, brand-name drugs.
• Individual results vary. Nothing in this article promises a specific result.
• Prescriptions are written by independent, licensed clinicians through OpenLoop Health and filled by licensed U.S. partner pharmacies.

Sources

1. Eli Lilly and Company. Tirzepatide injection for weight reduction and obstructive sleep apnea: prescribing information (dosage, boxed warning, limitations of use). U.S. FDA, 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s002lbl.pdf
2. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 2022. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
3. Garvey WT, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). The Lancet, 2023. https://www.sciencedirect.com/science/article/abs/pii/S014067362301200X
4. Wadden TA, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine, 2023. https://www.nature.com/articles/s41591-023-02597-w
5. U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. FDA. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
6. Eli Lilly and Company. Tirzepatide injection for type 2 diabetes: prescribing information (clinical pharmacology highlights). U.S. FDA, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
7. Early-onset obesity and tirzepatide treatment: a post hoc analysis of the SURMOUNT clinical trials. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC12381612/
8. PrescriberPoint. Tirzepatide for weight reduction: dosing and administration summary from the prescribing information, 2026. https://prescriberpoint.com/therapies/tirzepatide-487cd7e
9. MedCentral. Treatment guide for tirzepatide for obesity or overweight: dosing, administration and adverse effects. https://www.medcentral.com/drugs/guide/tirzepatide
10. ChoosingTherapy. Tirzepatide for weight loss: uses, dosage, side effects and warnings. https://www.choosingtherapy.com/tirzepatide/
11. HCPLive. SURMOUNT-1: tirzepatide provides significant, sustained weight loss in obesity (trial enrollment criteria). https://www.hcplive.com/view/surmount-1-tirzepatide-provides-significant-sustained-weight-loss-in-obesity